Time limited Experiential schema therapy: Naturalistic study for Groups of Outpatients with personality disorders (TENGO)

Phase 2

Withdrawn

Conditions: 10034726
Personality disorders

Registration Number: NL-OMON50656

Lead Sponsor: Parnassia (Den Haag)

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Withdrawn

Sex: Not specified

Target Recruitment: 78

Inclusion Criteria

1. Personality disorder
2. Age at least 18 years
3. Eligibility for group therapy based on a. symptoms of PD are the reason for
seeking help, the patient is motivated to follow psychotherapy in a group, and
c. the clinical impression of the group therapists. The latter means that the
patient is able to attend group meetings, the patient dares to show himself
within a group and the patient is able to reflect on the input of other
patients.

Exclusion Criteria

1. Acute crisis (suicidality) for which patient needed inpatient treatment,
2. Acute psychotic episode or psychotic disorder, autism spectrum disorder or
alcohol or drugs-related disorders as primary diagnosis
3. Limited knowledge of the Dutch language
4. Severe auditory problems that interfere with participation in a group, or
severe stuttering.
5. Estimated IQ below 70

Study & Design

Study Type: Observational non invasive

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Severity of general psychiatric symptoms (Brief Symptom Inventory)<br /><br>Severity of symptoms of personality disorders (Personality Inventory for DSM-5*<br /><br>Brief Form (PID-5-BF) </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Functioning in daily life (World Health Organization Disability Assessment<br /><br>Schedule 2.0, WHODAS-2)<br /><br>Data will be collected at baseline, midway and end of treatment, and 6 and 12<br /><br>months of follow-up.<br /><br>The following four predictive factors will be explored for treatment success<br /><br>and : signs of autism (AQ-10), rigidity (subdomain BRIEF-A), latent low scorers<br /><br>mode profile and severity of general psychiatric symptoms (Brief Symptom<br /><br>Inventory, BSI) after three months of treatment.</p><br>